Palatin Technologies, Inc. (PTN)

USD 0.75

(-9.64%)

Total Debt Summary of Palatin Technologies, Inc.

  • Palatin Technologies, Inc.'s latest annual total debt in 2024 was 590.33 Thousand USD , down -43.82% from previous year.
  • Palatin Technologies, Inc.'s latest quarterly total debt in 2024 Q4 was 426.55 Thousand USD , down -16.46% from previous quarter.
  • Palatin Technologies, Inc. reported annual total debt of 1.05 Million USD in 2023, down -8.93% from previous year.
  • Palatin Technologies, Inc. reported annual total debt of 1.15 Million USD in 2022, down -7.87% from previous year.
  • Palatin Technologies, Inc. reported quarterly total debt of 821.37 Thousand USD for 2024 Q2, down -12.09% from previous quarter.
  • Palatin Technologies, Inc. reported quarterly total debt of 934.32 Thousand USD for 2024 Q1, down -11.08% from previous quarter.

Annual Total Debt Chart of Palatin Technologies, Inc. (2024 - 1996)

Historical Annual Total Debt of Palatin Technologies, Inc. (2024 - 1996)

Year Total Debt Total Debt Growth
2024 590.33 Thousand USD -43.82%
2023 1.05 Million USD -8.93%
2022 1.15 Million USD -7.87%
2021 1.25 Million USD -1.09%
2020 1.26 Million USD 280.34%
2019 332.89 Thousand USD -94.7%
2018 6.28 Million USD -55.52%
2017 14.12 Million USD -28.38%
2016 19.71 Million USD 100.2%
2015 9.84 Million USD 0.0%
2014 - USD -100.0%
2013 19.9 Thousand USD -52.81%
2012 42.18 Thousand USD -45.29%
2011 77.1 Thousand USD 127.1%
2010 33.95 Thousand USD -72.08%
2009 121.62 Thousand USD -68.39%
2008 384.75 Thousand USD -21.79%
2007 491.96 Thousand USD 55.61%
2006 316.14 Thousand USD 946.75%
2005 30.2 Thousand USD -52.58%
2004 63.69 Thousand USD -75.91%
2003 264.44 Thousand USD 0.0%
2002 - USD -100.0%
2001 27.77 Thousand USD 0.0%
2000 - USD -100.0%
1999 2 Million USD 122.22%
1998 900 Thousand USD -50.0%
1997 1.8 Million USD -44.71%
1996 3.25 Million USD 0.0%

Peer Total Debt Comparison of Palatin Technologies, Inc.

Name Total Debt Total Debt Difference
AIM ImmunoTech Inc. 495 Thousand USD -19.26%
Ampio Pharmaceuticals, Inc. 274 Thousand USD -115.452%
Armata Pharmaceuticals, Inc. 120.37 Million USD 99.51%
Actinium Pharmaceuticals, Inc. 2.11 Million USD 72.062%
Azitra, Inc. 885.94 Thousand USD 33.366%
Can-Fite BioPharma Ltd. 39.99 Thousand USD -1375.882%
Chromocell Therapeutics Corporation 1.26 Million USD 53.469%
Calidi Biotherapeutics, Inc. 7.23 Million USD 91.842%
CEL-SCI Corporation 13.57 Million USD 95.65%
iBio, Inc. 4.46 Million USD 86.764%
Lineage Cell Therapeutics, Inc. 2.95 Million USD 80.002%
MAIA Biotechnology, Inc. - USD -Infinity%
Matinas BioPharma Holdings, Inc. 3.55 Million USD 83.399%
Navidea Biopharmaceuticals, Inc. 2.43 Million USD 75.749%
NovaBay Pharmaceuticals, Inc. 2.74 Million USD 78.455%
NanoViricides, Inc. - USD -Infinity%
Oragenics, Inc. 312.7 Thousand USD -88.786%
BiomX Inc. 15.09 Million USD 96.088%
BiomX Inc. 15.09 Million USD 96.088%
Protalix BioTherapeutics, Inc. 26.28 Million USD 97.754%
Scorpius Holdings, Inc. 14.04 Million USD 95.796%